Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice
- 2 May 2023
- journal article
- research article
- Published by Taylor & Francis in Future Cardiology
- Vol. 19 (6) , 343-351
Abstract
Aim: To estimate the projected effectiveness of dapagliflozin in subjects with heart failure (HF) with reduced ejection fraction in clinical practice in Spain. Materials & methods: This multicenter... Plain language summary Heart failure with reduced ejection fraction is a severe disease with a high risk of hospitalization and mortality. With this condition, the heart muscle cannot pump properly... Tweetable abstract The implementation of dapagliflozin may translate into substantial reductions in mortality and heart failure readmissions.Keywords
This publication has 26 references indexed in Scilit:
- Valor pronóstico a corto plazo de la proteína C reactiva en ancianos con insuficiencia cardíaca agudaRevista Clínica Española, 2019
- Medical Therapy for Heart Failure With Reduced Ejection FractionJACC, 2018
- The Vulnerable Phase of Heart FailureAmerican Journal of Therapeutics, 2018
- Basal functional status predicts one-year mortality after a heart failure hospitalization in elderly patients — The RICA prospective studyInternational Journal of Cardiology, 2018
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- The utility of heart failure registries: a descriptive and comparative study of two heart failure registriesPostgraduate Medical Journal, 2016
- Adecuación en España a las recomendaciones terapéuticas de la guía de la ESC sobre insuficiencia cardiaca: ESC Heart Failure Long-term RegistryRevista Espanola de Cardiologia, 2015
- A Contemporary Appraisal of the Heart Failure Epidemic in Olmsted County, Minnesota, 2000 to 2010JAMA Internal Medicine, 2015
- Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: Results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) programAmerican Heart Journal, 2010
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999